July 24, 2020

July 24, 2020

Frederick Locke, MD, on Real-world Results for CAR T-cell Tx for Relapsed/Refractory LBCL

MedPage Today – July 23

A new trial by Frederick S. Locke, MD, of Moffitt Cancer Center in Tampa, Florida, and colleagues, examined the real-world implications of axi-cel in the standard-of-care setting for these patients.


Fighting Cancer

WFLA – July 22

Dr. Javier Torres-Roca said the four deadliest cancers among latinos are lung, colorectal, breast and prostate cancer. Text version is here.


Tucson Tech: Startup aims to create new vaccines for COVID-19, future pathogens

Arizona Daily Star – July 22

Agrawal initially developed the foundations of the gene-delivery technology in his lab in the mid-2000s, while he was an assistant member of the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.


COVID-19 tests making Moffitt Cancer Center safer

WFTS – July 21

Moffitt Cancer Center is taking extra steps to keep their patients alive, and keeping its staff from getting COVID-19.


Dr. Komrokji on the Current Treatment Landscape in MDS

OncLive – July 21

Rami Komrokji, MD, professor, Medicine and Oncologic Sciences, College of Medicine, University of South Florida, senior member, Malignant Hematology and Experimental Therapeutics Program, and head of the Leukemia and MDS Section, Moffitt Cancer Center, discusses the current treatment landscape in myelodysplastic syndrome (MDS).


Moffitt Cancer Center appoints machine learning department chair 

Becker’s Hospital Review – July 21

Tampa, Fla.-based Moffitt Cancer Center tapped Issam El Naqa, PhD, as the founding chair of its new machine learning department, according to a July 20 news release. 


Parents of 1 in 2 unvaccinated U.S. adolescents have no intention to initiate HPV vaccine

Newswise – July 21

Other UTHealth School of Public Health authors include Yenan Zhu, MS; David R. Lairson, PhD; and Cici Bauer, PhD. Jane R. Montealegre, PhD, and Lindy U. McGee, MD, both of Baylor College of Medicine, and Anna R. Giuliano, PhD, of the Center for Immunization and Infection Research in Cancer at the Moffitt Cancer Center in Tampa, Florida, were also co-authors.


Transarterial chemoperfusion in mesothelioma patients

The Science Advisory Board – July 21

Results of a phase II clinical study, conducted by the Moffitt Cancer Center, demonstrated a 70% disease control rate and median overall survival rate of eight and a half months from the start of the chemoperfusion treatment.


Moffitt creates high-tech machine learning department to accelerate cancer research 

Tampa Bay Business Journal – July 20

Dr. Issam El Naqa started at Moffitt on Monday as the founding chair of the hospital's new machine learning department, which will be in the Division of Quantitative Science, and like all Moffitt departments will be focused on scientific discovery in cancer research.


Service Dog Helps Woman Get Through Cancer Treatments Thanks to ‘Super Suit’

Today.com – July 20

Geril gets treated at the Moffitt Cancer Center in Tampa, Florida. According to the center’s website, service dogs, guide dogs and therapy dogs are welcome in the building’s public spaces as long as they are well-behaved and remain under the control of their handlers.


Tampa Confidential: Sherrel Sampson

Tampa Bay Magazines – July 20

Furthermore, our amazing partners at Moffitt Cancer Center, Tampa International Airport and USF were instrumental in building community relationships and helping us grow our regional consumer base.


Gastrointestinal Malignancies Presented by Jonathan Strosberg, MD

OncLive – July 19

OncLive® is proud to present the Institutional Perspectives in Cancer (IPC). These virtual events assemble academic and community-based physicians and healthcare professionals across key disciplines from medical and surgical oncology.


Treating Geriatric Patients With Cancer During the COVID-19: Expert Offers Tips

Oncology Nursing News – July 19

In an interview with Oncology Nursing News' sister publication, OncLive, during the Institutional Perspectives in Cancer program, Sam, a hematologist and oncologist and an assistant member in the Department of Individualized Cancer Management/Senior Adult Oncology Program at Moffitt Cancer Center, highlighted strategies to prevent the spread of COVID-19 in geriatric patients with cancer and shared advice on how to overcome unique challenges faced in the care of this population.


‘Cancer doesn’t stop’ with coronavirus. Here’s how Tampa Bay patients manage the risk

 Tampa Bay Times – July 18

“Cancer doesn’t stop with COVID-19,” said Dr. Jeffrey Lancet, an oncologist and researcher at the Moffitt Cancer Center. “People are dealing with very serious advanced illnesses that require treatment and need to be addressed sooner rather than later.”


WSU team wins AMA grant for project to improve performance during medical student transitions

Wayne State University – July 17

Previous grant winners include Beth Israel Deaconess Medical Center, Harvard Medical School, the Brody School of Medicine at East Carolina University, the Cleveland Clinic, the H. Lee Moffitt Cancer Center and Research Institute, Johns Hopkins School of Medicine and Rutgers’ Robert Wood Johnson Medical School.


Can We Talk? WEDU PBS Hosts A Community Conversation About Race

WEDU – July 17                

Guests also scheduled to participate include: … Dr. B. Lee Green – VP of Diversity and Communications, Moffitt Cancer Center


Walking the tightrope: Balancing tumor response, adverse events of checkpoint inhibitors

Healio – July 17

For Ahmad A. Tarhini, MD, PhD, director of Cutaneous Clinical and Translational Research, and leader of the Cutaneous Neoadjuvant and Adjuvant Translational Science Program at H. Lee Moffitt Cancer Center and Research Institute, the ball cannot move forward until one fundamental question is answered. 

Dr. Czerniecki on the Importance of Multidisciplinary Efforts for Breast Cancer Brain/CNS Metastases

OncLive – July 16

Brian Czerniecki, MD, PhD, chair and senior member of the Department of Breast Oncology at Moffitt Cancer Center, discusses the importance of a multidisciplinary effort to treat patients with breast cancer who develop brain or central nervous system (CNS) metastases.


More Personalized Treatment Needed for Early Stage HER2+ Breast Cancer

Oncology Nursing News – July 17

In an interview with Oncology Nursing News' sister publication, OncLive, as part of the virtual Institutional Perspectives in Cancer™ on Breast Cancer, Han, a medical oncologist and research director of Breast Oncology at Moffitt Cancer Center, further discussed ongoing clinical trials within the field of HER2-positive breast cancer and the future of personalized treatment for this patient population.


Yes, People Of Color Get Skin Cancer, And It’s Deadlier: These Sunscreens Are Made Specifically For Darker Skin Tones

Survivor Net – July 17

“Growing up, I learned that middle-aged, fair-skinned Caucasian women were at high risk for skin cancer,” says Smith who says her melanoma showed up as a lump in her groin area. She was fortunate to see Dr. Vernon K. Sondak, Chair of the Department of Cutaneous Oncology at Moffitt Cancer Center in Tampa and a melanoma specialist, who urged her to join a clinical trial.



Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.